I have some DXB - another biotech. They did a 1 for 20 consolidation in 2017, and it certainly cleaned up the register of small holdings.
Since then the share price has dropped from the consolidation price (20 cents) to less than 9 cents today. No change in the company fundamentals - they're in Phase 2b trials (fully funded) following excellent results in Phase 2a.
So be careful what you wish for.
New Paul Hopper Interview, page-27
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.002(5.41%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 4.0¢ | 3.5¢ | $1.163M | 31.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2275218 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 196677 | 3 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
